This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Meena Meena, Ph.D.
Vice President of Bioanalytical, DMPK and Biomarke at Stoke Therapeutics


Meena is the vice president of bioanalytical, DMPK and biomarker development at Stoke Therapeutics. Prior to joining Stoke, Meena served as senior director of bioanalytical, pharmacology and biomarker development at Wave Life Sciences. She played a pivotal role in building Wave’s stereopure oligonucleotide chemistry platform and in guiding the clinical entry of three antisense programs. Earlier in her career, Meena worked at Alnylam Pharmaceuticals on siRNA chemistry and targeted siRNA delivery. Meena received her Ph.D. in chemistry with Dr. K.N. Ganesh at the National Chemical Laboratory in Pune, India, and did her postdoctoral research on nucleic acid analogs with Professor Larry W. McLaughlin at Boston College.

Agenda Sessions

  • Oligonucleotide STK-001 for the Treatment of Dravet Syndrome: Cross-species Biodistribution and Pharmacology and Efficacy in a Mouse Disease Model